Pioglitazone counteracts the tumor necrosis factor-α inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pioglitazone counteracts the tumor necrosis factor-α inhibition of follicle-stimulating hormone-induced follicular development and estradiol production in an in vitro mouse preantral follicle culture system
Authors
Keywords
Polycystic ovary syndrome, Pioglitazone, TNF-α, Follicle culture, PPAR-γ
Journal
Journal of Ovarian Research
Volume 6, Issue 1, Pages 69
Publisher
Springer Nature
Online
2013-09-30
DOI
10.1186/1757-2215-6-69
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Thiazolidinediones on Polycystic Ovary Syndrome: a Meta-analysis of Randomized Placebo-Controlled Trials
- (2012) Qiang Du et al. ADVANCES IN THERAPY
- Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
- (2012) Evanthia Diamanti-Kandarakis et al. ENDOCRINE REVIEWS
- Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome
- (2012) Young Sik Choi et al. STEROIDS
- Thiazolidinediones and PPARγ agonists: time for a reassessment
- (2012) Bertrand Cariou et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Bezafibrate Restores the Inhibition of FSH-Induced Follicular Development and Steroidogenesis by Tumor Necrosis Factor-Alpha Through Peroxisome Proliferator-Activated Receptor-Gamma Pathway in an In Vitro Mouse Preantral Follicle Culture1
- (2011) Shuichiro Hara et al. BIOLOGY OF REPRODUCTION
- Inflammation in Polycystic Ovary Syndrome: Underpinning of insulin resistance and ovarian dysfunction
- (2011) Frank González STEROIDS
- Differences in Collagen Expression in Cumulus Cells after Exposure to Highly Purified Menotropin or Recombinant Follicle-Stimulating Hormone in a Mouse Follicle Culture Model1
- (2009) Tom Adriaenssens et al. BIOLOGY OF REPRODUCTION
- Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome
- (2009) Chung-Hoon Kim et al. FERTILITY AND STERILITY
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- (2009) OBSTETRICS AND GYNECOLOGY
- Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells
- (2009) Qiuju Chen et al. Reproductive Biology and Endocrinology
- Use of metformin in polycystic ovary syndrome
- (2008) Ruchi Mathur et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Functional AR Signaling Is Evident in an In Vitro Mouse Follicle Culture Bioassay That Encompasses Most Stages of Folliculogenesis1
- (2008) Sandy Lenie et al. BIOLOGY OF REPRODUCTION
- Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome
- (2008) H OTA et al. FERTILITY AND STERILITY
- Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
- (2008) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin for the Treatment of the Polycystic Ovary Syndrome
- (2008) John E. Nestler NEW ENGLAND JOURNAL OF MEDICINE
- The expression of tumor necrosis factor-alpha, its receptors and steroidogenic acute regulatory protein during corpus luteum regression
- (2008) Michael Abdo et al. Reproductive Biology and Endocrinology
- Peroxisome proliferator-activated receptor-γ ligand reduced tumor necrosis factor-α-induced interleukin-8 production and growth in endometriotic stromal cells
- (2007) Yoko Ohama et al. FERTILITY AND STERILITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started